NPS announced in December that the European Medicines Agency validated its marketing authorization application and started its review of the drug. "NPS Hormone Drug Gets FDA Approval," at 7:54 p.m. EST on Friday, misstated the drug got EMA approval in the ninth paragraph.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Nps (NASDAQ:NPSP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Nps
Nps (NASDAQ:NPSP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Nps